NUTRA PHARMA CORP.: 10-Q filed 2021-11-10
What NUTRA PHARMA CORP. reported in its quarterly report filed 2021-11-10 (fiscal Q3 2021): 38 published measures, 102 facts as tagged in accession 0001493152-21-027793.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-11-10
- Fiscal period
- fiscal Q3 2021
- Accession
- 0001493152-21-027793 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTRA PHARMA CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 835,248 | USD | |
| At 2020-12-31 | 301,786 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 24,455,929 | USD | |
| At 2020-12-31 | 11,795,601 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -23,620,681 | USD | |
| At 2020-12-31 | -11,493,815 | USD | |
| At 2020-09-30 | -9,645,052 | USD | |
| At 2020-06-30 | -10,431,780 | USD | |
| At 2019-12-31 | -11,701,035 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 15,433,385 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -15,264,552 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 587,768 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 1,264,323 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | -1,510,789 | USD | 273 |
| 2020-01-01 to 2020-09-30 | -525,263 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 34,768 | USD | 273 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 19,266 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 71,748 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 13,372 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 36,728 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 1,832,807 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 525,263 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | -277,268 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -83,898,020 | USD | |
| At 2020-12-31 | -68,633,468 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 7,289,196,290 | shares | 92 |
| 2021-01-01 to 2021-09-30 | 7,201,163,176 | shares | 273 |
| 2020-07-01 to 2020-09-30 | 6,639,683,067 | shares | 92 |
| 2020-01-01 to 2020-09-30 | 6,512,418,374 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 12,670,053,386 | shares | 92 |
| 2021-01-01 to 2021-09-30 | 7,201,163,176 | shares | 273 |
| 2020-07-01 to 2020-09-30 | 13,075,446,759 | shares | 92 |
| 2020-01-01 to 2020-09-30 | 13,006,720,704 | shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 43,332 | USD | |
| At 2020-12-31 | 14,742 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 64,750 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 66,195 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 0 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 8,500 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | -512,310 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -1,492,225 | USD | 273 |
| 2020-07-01 to 2020-09-30 | -183,753 | USD | 92 |
| 2020-01-01 to 2020-09-30 | -569,729 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 572,116 | USD | |
| At 2020-12-31 | 55,351 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 23,775,475 | USD | |
| At 2020-12-31 | 11,482,607 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 611,944 | USD | |
| At 2020-12-31 | 599,428 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 41,438 | USD | |
| At 2020-12-31 | 37,080 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 521,932 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 1,539,689 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 194,019 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 594,387 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 33,008 | USD | |
| At 2020-12-31 | 5,271 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 9,622 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 47,464 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 10,266 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 24,658 | USD | 274 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 556,932 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 1,501,689 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 253,019 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 723,887 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 7,308,485,964 | shares | |
| At 2020-12-31 | 6,955,197,214 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | -23,620,681 | USD | |
| At 2021-06-30 | -39,244,098 | USD | |
| At 2020-09-30 | -9,645,052 | USD | |
| At 2019-12-31 | -11,701,035 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 112,117 | USD | |
| At 2020-12-31 | 144,010 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 95,635 | USD | |
| At 2020-12-31 | 143,320 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 262,611 | USD | |
| At 2020-12-31 | 227,843 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 219,279 | USD | |
| At 2020-12-31 | 213,101 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 814,146 | USD | |
| At 2020-12-31 | 780,432 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-09-30 | 191,955 | USD | |
| At 2020-12-31 | 10,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 15,433,385 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -15,264,552 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 587,768 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 1,264,323 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 2,793 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 6,178 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 1,105 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 2,529 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-07-01 to 2021-09-30 | 15,945,695 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -13,772,327 | USD | 273 |
| 2020-07-01 to 2020-09-30 | 771,521 | USD | 92 |
| 2020-01-01 to 2020-09-30 | 1,834,052 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 41,951 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 4,359 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 4,334 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 47,737 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 11,335 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-09-30 | 12,516 | USD | 273 |
| 2020-01-01 to 2020-09-30 | 1,832 | USD | 274 |
Inspect the source
- Entity
- NUTRA PHARMA CORP. / CIK 0001119643
- Captured
- 2026-09-20T05:24:45.365Z
- SEC response SHA-256
a9ccf17d1b07544de23a6dd72641e83d2b0b8f34b5c47b58fd5a236f1c887339
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001119643.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))